Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up.
Hupperets P, Wils J, Volovics L, Schouten L, Fickers M, Bron H, Schouten H, Jager J, de Jong J, Beex L, et al. Hupperets P, et al. Among authors: volovics l. Ann Oncol. 1995 Jan;6(1):90-1. doi: 10.1093/oxfordjournals.annonc.a059059. Ann Oncol. 1995. PMID: 7710989 Free article. Clinical Trial. No abstract available.
Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients.
Hupperets PS, Wils J, Volovics L, Schouten L, Fickers M, Bron H, Schouten HC, Jager J, Smeets J, de Jong J, et al. Hupperets PS, et al. Among authors: volovics l. Ann Oncol. 1993 Apr;4(4):295-301. doi: 10.1093/oxfordjournals.annonc.a058485. Ann Oncol. 1993. PMID: 8518219 Free article. Clinical Trial.
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up.
Hupperets PS, Wils JA, Volovics L, Schouten LJ, Fickers MM, Bron HN, Jager JJ, de Jong JM, Blijham GH. Hupperets PS, et al. Among authors: volovics l. Breast. 2001 Feb;10(1):35-7. doi: 10.1054/brst.2000.0180. Breast. 2001. PMID: 14965556 Clinical Trial.
Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation.
Jager JJ, Langendijk JA, Dohmen JP, Schreutelkamp IL, Volovics L, van Engelshoven JM, de Jong JM, Schouten LJ, Hupperets PS, Blijham GH. Jager JJ, et al. Among authors: volovics l. Br J Radiol. 1995 Jul;68(811):754-60. doi: 10.1259/0007-1285-68-811-754. Br J Radiol. 1995. PMID: 7640932
14 results